- Home
- ALEC vs JRS Comparison
ALEC vs JRS Comparison
Compare ALEC & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.87
Company Overview
Basic Information| Metric | ALEC | JRS |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.2M | 219.9M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALEC | JRS |
|---|---|---|
| Price | $1.87 | $7.89 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 86.6K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,048,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.26 | N/A |
| 52 Week Low | $0.87 | $5.95 |
| 52 Week High | $3.40 | $8.00 |
Technical Indicators
Market Signals| Indicator | ALEC | JRS |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 66.24 |
| Support Level | $1.74 | $7.55 |
| Resistance Level | $1.94 | $7.70 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 76.26 | 100.00 |
Price Performance
Historical Comparison ALEC
JRS
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.